Insider: Geary Richard S EVP, Chief Development Officer - IONIS PHARMACEUTICALS INC
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 59,657 | 0 | 59,657 |
| Value | $4,461,747.03 | $0.00 | $4,461,747.03 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 11/03/2025 | DDS | 905 | Direct | COM | $75.05 | $67,923.87 | 59,657 |
| 11/03/2025 | DDS | 775 | Direct | COM | $75.05 | $58,166.85 | 59,657 |
| 10/31/2025 | DDS | 34,664 | Direct | COM | $75.11 | $2,603,554.11 | 79,657 |
| 10/31/2025 | DDS | 34,585 | Direct | COM | $75.11 | $2,597,620.56 | 79,657 |
| 10/31/2025 | DDS | 20,000 | Direct | COM | $75.11 | $1,502,166.00 | 59,657 |
| 09/30/2025 | DDS | 57,900 | Direct | COM | $65.24 | $3,777,668.13 | 79,657 |
| 09/02/2025 | DDS | 10,000 | Direct | COM | $50.37 | $503,671.00 | 79,657 |
| 08/05/2025 | DDS | 10,000 | Direct | COM | $42.86 | $428,593.00 | 89,492 |
| 01/31/2025 | DDS | 1,406 | Direct | COM | $32.40 | $45,561.29 | 99,077 |
| 01/16/2025 | DDS | 7,072 | Direct | COM | $32.86 | $232,407.14 | 96,663 |
| 08/29/2024 | DDS | 331 | Direct | COM | $49.63 | $16,427.53 | 84,823 |
| 08/28/2024 | DDS | 320 | Direct | COM | $49.16 | $15,731.20 | 85,154 |
| 08/05/2024 | DDS | 2,430 | Direct | COM | $48.00 | $116,640.00 | 85,508 |
| 02/02/2024 | DDS | 1,961 | Direct | COM | $50.04 | $98,134.91 | 87,334 |
| 01/17/2024 | DDS | 7,338 | Direct | COM | $50.42 | $369,959.95 | 85,475 |
| 12/21/2023 | DDS | 4,112 | Direct | COM | $49.29 | $202,680.89 | 72,961 |
| 12/20/2023 | DDS | 6,500 | Direct | COM | $49.64 | $322,643.10 | 72,961 |
| 12/14/2023 | DDS | 6,571 | Direct | COM | $49.21 | $323,380.59 | 72,961 |
| 12/14/2023 | DDS | 4,042 | Direct | COM | $50.19 | $202,855.85 | 72,961 |
| 02/06/2023 | DDS | 1,920 | Direct | COM | $40.66 | $78,070.08 | 72,385 |
| 01/18/2023 | DDS | 7,873 | Direct | COM | $39.57 | $311,525.16 | 70,483 |
| 01/13/2021 | DDS | 141 | Direct | COM | $59.50 | $8,389.50 | 30,306 |
| 11/25/2020 | DDS | 11,920 | Direct | COM | $50.05 | $596,596.00 | 30,447 |
| 11/24/2020 | DDS | 2,380 | Direct | COM | $50.83 | $120,975.40 | 30,447 |
| 11/23/2020 | DDS | 10,700 | Direct | COM | $50.11 | $536,177.00 | 30,447 |
| 1 2 Next Last You are at page 1 of 2 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2026 Zacks Investment Research